Drug firms donate compounds for anti-HIV gel.
作者信息
Towie Narelle
出版信息
Nature. 2005 Nov 3;438(7064):6-7. doi: 10.1038/438006b.
DOI:10.1038/438006b
PMID:16267513
Abstract
摘要
相似文献
1
Drug firms donate compounds for anti-HIV gel.
Nature. 2005 Nov 3;438(7064):6-7. doi: 10.1038/438006b.
2
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Nature. 2005 Nov 3;438(7064):99-102. doi: 10.1038/nature04055. Epub 2005 Oct 30.
3
Public health. Regulatory challenges in microbicide development.
Science. 2004 Jun 25;304(5679):1911-2. doi: 10.1126/science.1100441.
4
Trial and failure.
Nature. 2007 Mar 1;446(7131):1. doi: 10.1038/446001a.
5
Microbicide data show promise.
AIDS Patient Care STDS. 2009 Mar;23(3):223-4.
6
After microbicide failures, hope that antiviral approach will gel.
Nat Med. 2008 Apr;14(4):354. doi: 10.1038/nm0408-354a.
7
Starting to gel.
Nature. 2004 Jul 8;430(6996):138-40. doi: 10.1038/430138a.
8
Drug firms drop drug case against South Africa.
AIDS Policy Law. 2001 May 11;16(9):3.
9
Study of anti-HIV gel shows promise--what's the next step? Look to upcoming results from Phase III trial.
AIDS Alert. 2009 May;24(5):55-7.
10
Gilead's deal of a lifetime.
Nat Biotechnol. 2009 May;27(5):423. doi: 10.1038/nbt0509-423.
Zotero 插件